Skip to main content
ChemPartner PharmaTech Co., Ltd. logo

ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings

Ticker · 300149 ISIN · CNE100000Y27 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,256 across all filing types
Latest filing 2017-03-05 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 300149

About ChemPartner PharmaTech Co., Ltd.

https://www.chempartner.com

ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.

Recent filings

Filing Released Lang Actions
2016年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2016 年年度报告摘要" which translates to "2016 Annual Report Summary". It contains detailed financial data for the year 2016, including revenue, net profit, quarterly financial data, shareholder information, business overview, management discussion, and accounting policies. The document is over 8,000 characters, indicating it is a substantive report rather than a brief announcement. It includes audited financial statements and comprehensive business analysis typical of an annual report. Therefore, this document fits the definition of an Annual Report (10-K).
2017-03-05 Chinese
关于继续使用闲置自有资金和募集资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the continued use of idle self-owned funds and raised funds for cash management purposes. It details the board and supervisory committee approvals, investment purposes, amounts, types of investments, risk analysis, and related opinions from independent directors and the sponsoring institution. The document does not contain financial statements or detailed financial performance data but rather describes a financing and investment activity related to the company's capital management. It is a formal announcement about capital usage and investment plans, not a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is about 5,087 characters, which is sufficient for a detailed announcement but not a full report like an annual or interim report.
2017-03-05 Chinese
独立董事2016年度述职报告（王林）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2016 Annual Work Report" for a company, detailing the independent director's attendance at meetings, opinions on company matters, committee work, investigations, investor protection efforts, and training during the year 2016. It is a detailed report of the independent director's duties and activities over the year, not a general annual report or financial statement. It does not contain financial statements or earnings data, nor is it an announcement or proxy material. This fits the category of Board/Management Information (MANG), which includes announcements or reports related to board members and senior management activities. The document length is 2708 characters, which is consistent with a detailed report but not a full annual report. Therefore, the classification is MANG with high confidence.
2017-03-05 Chinese
关于继续开展期货套期保值业务的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by a company regarding the continuation of its futures hedging business for raw material price risk management. It details the purpose, scope, risk analysis, and internal controls related to the futures hedging activities. The document includes board and supervisory committee meeting approvals and independent director opinions. It does not contain financial statements or quarterly/yearly financial results, nor is it a transcript or presentation. It is a regulatory announcement about a specific business activity and risk management, not a financial report or earnings release. The document length is about 3,000 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the best fitting category is Regulatory Filings (RNS), as it is a general regulatory announcement about the company's hedging business and risk controls.
2017-03-05 Chinese
2016年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an audit report for the fiscal year 2016 of Quantum Hi-Tech (China) Biological Co., Ltd. It contains detailed audited financial statements including consolidated and parent company balance sheets, income statements, cash flow statements, and statements of changes in equity. The document includes the auditor's opinion, responsibilities of management and auditors, and extensive financial data and notes. The presence of a formal audit opinion and comprehensive financial statements indicates this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR).
2017-03-05 Chinese
2016年年度报告披露的提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (335 characters) stating that the company's 2016 Annual Report and summary were disclosed on March 6, 2017, on the designated disclosure website. It does not contain the actual annual report or financial data but merely informs investors to review the report elsewhere. This fits the pattern of a Report Publication Announcement (RPA) rather than the Annual Report (10-K) itself.
2017-03-05 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.